KETAN PATEL

Profile

First Name

: KETAN

Middle Name

:

Last Name

: PATEL

Related Companies
Titles
Company Name
Related People
DIRECTOR
INTELLEFLEX CORP
RICHARD BRAVMAN, JANETTE CHOCK, MICHAEL P DIERKS, JULIE ENGLAND, LINNEA GEISS, TOM HAWKINS, PETER MEHRING, ROBERT SCHWARTZ
DIRECTOR
SHOPWELL SOLUTIONS, INC.
BRENDAN BOYLE, ANTONY F. BRYDON, L. JASMINE KIM, IIYA B. NYKIN, ILYA B. NYKIN, FRANKLIN RIMALOVSKI, ROBERT ROSENBERG, DAVID STRONG, BRIAN WITLIN
DIRECTOR
ACLARIS THERAPEUTICS, INC.
KAMIL ALI-JACKSON, KEVIN BALTHASER, RICHARD A. BIERLY, ALBERT CHA, HUGH DAVIS, BRETT FAIR, DAVID GORDON, MAXINE GOWEN, WILLIAM HUMPHRIES, JAMES LOEROP, ANAND MEHRA, VINCENT MILANO, CHRISTOPHER MOLINEAUX, JOSEPH MONAHAN, CHRISTOPHER POWALA, ANDREW POWELL, BRYAN REASONS, FRANK RUFFO, ANDREW SCHIFF, STUART SHANLER, STUART D. SHANLER, STEPHEN TULLMAN, STEPHEN A. TULLMAN, STEVEN A. TULLMAN, NEAL WALKER
PROMOTER
RAINMAKER HOLDINGS II, LLC
PRAKASH MAGGAN, BHAVISHA PATEL, DIPAK PATEL, SUNIL PATEL
DIRECTOR
IVENIX, INC.
JESSE AMBROSINA, THOMAS BASSINGER, BENJAMIN BULKLEY, JEFFREY CARLISLE, JOHN CLARKE, JOHN K. CLARKE, DARRELL CRATE, DARRELL J. CRATE, JOHN DOUGLASS, JOHN M. DOUGLASS, COLIN J. FOSTER, GEORGE GRAY, GEORGE W. GRAY, CHARLES HADLEY, BRANDON HULL, LAWRENCE KUBA, WEI LI, CAROLYN MALLECK, BRENT NIBARGER, STUART RANDLE, JOHN SOKOLOWSKI, CHRISTIAN TAUBMAN, WAYNE B. WEISMAN, JOHN WU
DIRECTOR
GENOA PHARMACEUTICALS, INC.
TIBA AYNECHI, LYN BARANOWSKI, DANIEL D. BURGESS, JILL CARROLL, SOFIA IOANNIDOU, MICHAEL J. KAMDAR, JONATHAN LEFF, JONATHAN LEFF, M.D., CASSANDRA GIANNA LUCA, ROBERT MITTENDORFF, PETER MOLDT, A. BRUCE MONTGOMERY, BRUCE MONTGOMERY, M.D., NIALL O-DONNELL, HEATHER PRESTON, NAVEED SIDDIQI, MARK W. SURBER, PH.D., RICHARD G. VINCENT
DIRECTOR
NFLECTION THERAPEUTICS, INC.
MARK DE SOUZA, COREY GOODMAN, JOSH GRASS, WILLIAM HODDER, CHRISTOPHER POWALA, MICHAEL WOOTTON
DIRECTOR
MENLO THERAPEUTICS, INC.
SHARON BARBARI, STEVEN BASTA, STEVEN L. BASTA, ANTHONY BRUNO, ALBERT CHA, DAVID COLLIER, JOHN CREECY, DAVID DOMZALSKI, TED EBEL, MUTYA HARSCH, JAMES LARRICK, PATRICK LEPORE, ANDREW PERLMAN, AARON ROYSTON, ELISABETH SANDOVAL, EDWARD SCHNIPPER, IAIN STUART, SCOTT WHITCUP, TYLER ZERONDA
DIRECTOR
AMPHORA MEDICAL, INC.
MARC GALLETTI, MICHAEL LIANG, CHRIS OWENS, THOMAS V. RESSEMANN, TOM RESSEMANN, DAN SACHS, PETER K SHAGORY, THOMAS THALER, NICOLE J. WALKER, ROBERT WEISSKOFF
EXECUTIVE OFFICER
FOREST CITY REALTY TRUST, INC.
LOWELL BARON, FRANK COSTANZO, MATTHEW P. ELSESSER, MURRAY GOLDFARB, EMILY HOLIDAY, SWARUP KATURI, CRISTIANO MACHADO, CHRISTOPHER M. MELLIS, ABRAM NAPARSTEK, CHARLES OBERT, J. MATTHEW SHADY
DIRECTOR
AZAD ALLIANCE 2019 LLC
LEGACY PARTNERS LLC AZAD, ROBERT PARSEKIAN
DIRECTOR
AVALYN PHARMA INC.
TIBA AYNECHI, LYN BARANOWSKI, DANIEL D. BURGESS, JILL CARROLL, SOFIA IOANNIDOU, MICHAEL J. KAMDAR, JONATHAN LEFF, JONATHAN LEFF, M.D., CASSANDRA GIANNA LUCA, ROBERT MITTENDORFF, PETER MOLDT, A. BRUCE MONTGOMERY, BRUCE MONTGOMERY, M.D., NIALL O-DONNELL, HEATHER PRESTON, NAVEED SIDDIQI, MARK W. SURBER, PH.D., RICHARD G. VINCENT
DIRECTOR
RALLYBIO HOLDINGS, LLC
HELEN M. BOUDREAU, WENDY K. CHUNG, JEFFREY FRYER, JEFFREY M. FRYER, ROB HOPFNER, ROBERT HOPFNER, RON HUNT, RONALD M. HUNT, LUCIAN IANCOVICI, JONATHAN I. LIEBER, HUI LIU, MARTIN MACKAY, MARTIN W. MACKAY, CHRISTINE A. NASH, KUSH PARMAR, KUSH M. PARMAR, TIM SHANNON, PAULA SOTEROPOULOS, STEPHEN UDEN
EXECUTIVE OFFICER
REDIRECT HEALTH, LLC
DARRYL BAKER, DAVID BERG, GUY BERRY, PAUL JOHNSON, JANICE JOHNSTON, MARK MIOLA
EXECUTIVE OFFICER, DIRECTOR
FOREST CITY ENTERPRISES, L.P.
FRANK CONSTANZO, FRANK COSTANZO, CHRISTOPHER M. MELLIS, CHARLES OBERT
DIRECTOR
AVIVOMED INC.
CASPER DE CLERCQ, MUDIT K. JAIN, STEPHEN MASSON, PAUL MAZANEC, THERESA C. PAPPAS, DOUGLAS REED
DIRECTOR
ABK BIOMEDICAL INC
BOB ABRAHAM, ARAVIND AREPALLY, LUCY BATANEANT, AARON BEREZ, CARISSA BLACK, CARISSA BELLARDINE BLACK, DAVID DOBROWSKI, DAVID DOBROWSKY, GARY DONOFRIO, JAMES EADIE, MARC GREGOIRE, ANTHONY HEADLEY, MICHAEL MANGANO, JAMES MCLAREN, ROBERT ORR, KETEN PATEL, JOSEPH SILETTO, MICHAEL TYSON, MIKE TYSON
DIRECTOR
FC 1275 NJ MEMBER LLC
BENJAMIN S. BROWN, FRANK COSTANZO, KATHLEEN G. KANE, SABRINA KANNER, CHRISTOPHER M. MELLIS, CHARLES OBERT, RICKY TANG
EXECUTIVE OFFICER, DIRECTOR
FC TOD MF II HOLDINGS LLC
FRANK COSTANZO, CHARLES OBERT
EXECUTIVE OFFICER, DIRECTOR
FC TOD BTR HOLDINGS I LLC
FRANK COSTANZO, CHARLES OBERT
DIRECTOR
COMANCHE BIOPHARMA CORP.
PAUL ANTINORI, ALLISON AUGUST, BRENDAN BULIK-SULLIVAN, ALLYSON FELIX, SCOTT GOTTLIEB, DAVID GRAYZEL, THOMAS SCOTT JOHNSON, ARTHUR LEVIN, MUZAMMIL MANSURI, CLIVE MEANWELL, ANN TAYLOR, MICHAEL YOUNG
DIRECTOR
LOS ANGELES BIOSCIENCES, INC.
DERYA L. KELTER, JEFF NICHOLS
PROMOTER
RAINMAKER CAPITAL LLC
PRAKASH T. MAGGAN, PRADIPKUMAR PATEL, VEESHAL RAMA
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2026-04-16 
2026-04-21
D
Link
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2026-04-15 
2025-06-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-09 
2024-07-03
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-03 
2024-01-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-14 
2023-11-27
D
Link
 
 
DECLINE TO DISCLOSE 
Equity 
2023-11-14 
2023-10-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-22 
2023-07-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-07-07 
2023-05-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-28 
2023-03-13
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-13 
2023-02-21
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2023-02-10 
2023-01-11
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-30 
2023-01-11
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-30 
2022-12-22
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-05 
2022-09-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-09 
2022-06-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-07 
2022-06-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-07 
2022-02-07
D
Link
 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-01 
2021-11-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-03 
2021-10-12
D
Link
 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-12 
2021-03-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2021-03-03 
2021-03-23
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-22 
2020-05-29
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-27 
2020-05-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-24 
2020-04-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-30 
2020-04-13
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-27 
2019-02-26
D
Link
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-15 
2019-01-30
D
Link
REITS AND FINANCE 
REAL ESTATE INVESTMENT TRUSTS [6798] 
DECLINE TO DISCLOSE 
Equity 
2019-01-25 
2017-07-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-14 
2017-07-27
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-17 
2017-05-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-13 
2017-03-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-13 
2017-03-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-07 
2017-01-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-30 
2015-09-11
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-08-28 
2015-09-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-21 
2014-10-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-30 
2013-10-02
D
Link
LODGING AND CONVENTIONS 
 
NO REVENUES 
Equity 
2013-10-01 
2012-12-20
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-11-20 
2012-10-19
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-05 
2012-10-05
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-09-14 
2012-09-10
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2012-08-30 
2012-06-28
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-06-07 
2011-09-12
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-26